Fulgent’s arsenal has expanded to include a monkeypox test. Just as its record testing run for Covid-19 appears to be tapering off, Temple City-based Fulgent Genetics Inc. has added testing for ...

In just over two years, Temple City-based Fulgent Genetics Inc. has grown from a modest genetic testing company with $32 million in annual revenue to a behemoth with nearly $1 billion in revenue last ...

Fulgent Genetics is transitioning from a diagnostic business to a fully integrated healthcare company, with a focus on oncology. Despite past reliance on COVID-19 test revenues, Fulgent's core ...

Fulgent updates full year 2022 core revenue guidance to approximately $175 million including potential revenue contribution from proposed acquisition Fulgent Genetics continues to build upon its ...

Genetic testing company Fulgent Genetics has agreed to acquire pathology lab Inform Diagnostics for $170 million. Inform Diagnostics is one of the largest national pathology labs in the U.S. and ...

Genetic testing company Fulgent Genetics opened a next-generation sequencing lab in El Monte, Calif., and appointed or promoted four people across its leadership team. Fulgent said in a May 3 news ...

Proposed acquisition will add new anatomic pathology services, proprietary PCR tests and a national client base Fulgent Genetics continues to build upon its laboratory services platform both ...